Ted William Karkus is CEO & CHAIRMAN of ProPhase Labs, Inc.. Currently has a direct ownership of 3.43 Million shares of PRPH, which is worth approximately $2.09 Million. The most recent transaction as insider was on Apr 05, 2023, when has been sold 50,000 shares (Common Stock, par value $0.005) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.43M
0% 3M change
0% 12M change
Total Value Held $2.09 Million

Ted William Karkus Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 05 2023
SELL
Bona fide gift
-
50,000 Reduced 1.44%
3,433,750 Common Stock, par valu...
Apr 03 2023
SELL
Bona fide gift
-
100,000 Reduced 2.79%
3,483,750 Common Stock, par valu...
Feb 01 2023
SELL
Payment of exercise price or tax liability
$2,194,996 $8.18 p/Share
268,337 Reduced 6.97%
3,583,750 Common Stock, par valu...
Feb 01 2023
BUY
Exercise of conversion of derivative security
$300,000 $0.6 p/Share
500,000 Added 11.49%
3,852,087 Common Stock, par valu...
Jan 13 2023
SELL
Payment of exercise price or tax liability
$2,988,002 $9.36 p/Share
319,231 Reduced 8.7%
3,352,087 Common Stock, par valu...
Jan 13 2023
BUY
Exercise of conversion of derivative security
$360,000 $0.6 p/Share
600,000 Added 14.05%
3,671,318 Common Stock, par valu...
Oct 16 2022
SELL
Payment of exercise price or tax liability
$3,302,999 $10.41 p/Share
317,291 Reduced 9.36%
3,071,318 Common Stock, par valu...
Oct 16 2022
BUY
Exercise of conversion of derivative security
$360,000 $0.6 p/Share
600,000 Added 15.04%
3,388,609 Common Stock, par valu...
Aug 10 2022
SELL
Payment of exercise price or tax liability
$3,431,998 $10.84 p/Share
316,605 Reduced 10.2%
2,788,609 Common Stock, par valu...
Aug 10 2022
BUY
Exercise of conversion of derivative security
$360,000 $0.6 p/Share
600,000 Added 16.19%
3,105,214 Common Stock, par valu...
May 23 2022
SELL
Payment of exercise price or tax liability
$2,356,837 $8.47 p/Share
278,257 Reduced 10.0%
2,505,214 Common Stock, par valu...
May 23 2022
BUY
Exercise of conversion of derivative security
$900,000 $2.0 p/Share
450,000 Added 13.92%
2,783,471 Common Stock, par valu...
Jun 03 2021
BUY
Open market or private purchase
$172,091 $5.07 p/Share
33,943 Added 1.43%
2,333,471 Common Stock, par valu...
May 07 2021
SELL
Bona fide gift
-
120,000 Reduced 4.96%
2,299,528 Common Stock, par valu...
TWK

Ted William Karkus

CEO & CHAIRMAN
Garden City,, NY

Track Institutional and Insider Activities on PRPH

Follow ProPhase Labs, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRPH shares.

Notify only if

Insider Trading

Get notified when an Pro Phase Labs, Inc. insider buys or sells PRPH shares.

Notify only if

News

Receive news related to ProPhase Labs, Inc.

Track Activities on PRPH